By contrast, in an updated meta-analysis of 86 published studies of the association of the polymorphism with CHD, the excess CHD risk in TT homozygotes compared to CC homozygotes was 15%
What if I want to Pick up my order

Molecular Characteristics Molecular Type: Synthetic tetrapeptide bioregulator CAS Identifier: 307297-39-8 Molecular Formula: C14H22N4O9 Molecular Weight: 390.349 g/mol Structure: Linear synthetic peptide Form: Lyophilised powder Stability: High under recommended storage conditions Storage and Handling Recommendations Store in a cool, dry laboratory environment Maintain storage temperature at 20C for long-term stability Protect from moisture and prolonged light exposure Avoid repeated freezethaw cycles Follow institutional laboratory safety procedures Solubility and Laboratory Compatibility Bacteriostatic water Sterile saline solutions Mild acidic laboratory buffers Selected organic analytical solvents Product Specifications product Name Epitalon (Epithalon) 50mg brand BioPeptides cas 307297-39-8 quantity 50 mg vial purity 99% (HPLC verified) form Lyophilised peptide powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Synthetic tetrapeptide classification Research use only Manufacturing and Analytical Verification Solid-phase peptide synthesis (SPPS) for sequence accuracy High-performance liquid chromatography (HPLC) purification Mass spectrometry verification of molecular identity Batch-to-batch consistency validation Laboratory analytical documentation for traceability Regulatory Status Biopeptides Epitalon (Epithalon) 50mg is supplied exclusively for laboratory research and scientific investigation

Providers can sign up for early access here: To view or add a comment, sign in For anyone interested in the status of the PCAC meeting (FDA and Peptides), here is a good (and not too long!) update
What it does: Shows strong potential in animal studies for healing tendons, gut lining, nerves, and bone
These include: Injection-site reactions redness, localized pain, swelling, itching, or bruising where subcutaneous or intramuscular injections are given